The Use of Bevacizumab as a Modulator of Wound Healing Following Trabeculectomy Surgery

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2016
This is a phase III randomised controlled pilot study which aims to assess the effectiveness of the use of bevacizumab in patients who have undergone trabeculectomy surgery, which appear to be showing early signs of failure.
Epistemonikos ID: a6f558f46ebb4b5f4aa2f98a1b74b92892afb4ab
First added on: Mar 24, 2022